Skip to main content
SpringerLink
Log in

Image-Guided and Radioguided Surgery

  • Chapter
  • First Online:
Nuclear Medicine Textbook

Abstract

Together with PET, radioguided surgery is the nuclear medicine application that has experienced the most relevant growth in the last 15 years. The simple term “radioguided surgery” actually constitutes a wide range of combined procedures based on synergistic collaboration between at least two different specialties, nuclear medicine and surgery, but often involves other specialties as well; correct application of such procedures ensues obvious immediate and long-term benefits to the patient.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Zaknun JJ, Giammarile F, Valdés Olmos R, Vidal-Sicart S, Mariani G. Changing paradigms in radioguided surgery and intraoperative imaging: the GOSTT concept. Eur J Nucl Med Mol Imaging. 2012;39:1–3.

    PubMed  Google Scholar 

  2. Valdés Olmos RA, Vidal-Sicart S, Giammarile F, Zaknun JJ, Van Leeuwen FW, Mariani G. The GOSTT concept and hybrid mixed/virtual/augmented reality environment radioguided surgery. Q J Nucl Med Mol Imaging. 2014;58:207–15.

    PubMed  Google Scholar 

  3. Nieweg OE, Tanis PJ, Kroon BBR. The definition of a sentinel node. Ann Surg Oncol. 2001;9:538–41.

    Google Scholar 

  4. Zurrida S, Veronesi U. Milestones in breast cancer treatment. Breast J. 2015;21:3–12.

    CAS  PubMed  Google Scholar 

  5. Liu Y. Role of FDG PET-CT in evaluation of locoregional nodal disease for initial staging of breast cancer. World J Clin Oncol. 2014;5:982–9.

    PubMed  PubMed Central  Google Scholar 

  6. Beek MA, Verheuvel NC, Luiten EJ, Klompenhouwer EG, Rutten HJ, Roumen RM, et al. Two decades of axillary management in breast cancer. Br J Surg. 2015;102:1658–64.

    CAS  PubMed  Google Scholar 

  7. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer patients with clinically negative lymph-nodes. Lancet. 1997;349:1864–7.

    CAS  PubMed  Google Scholar 

  8. Giuliano AE, Gangi A. Sentinel node biopsy and improved patient care. Breast J. 2015;21:27–31.

    PubMed  Google Scholar 

  9. Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305:569–75.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Li CZ, Zhang P, Li RW, Wu CT, Zhang XP, Zhu HC. Axillary lymph node dissection versus sentinel lymph node biopsy alone for early breast cancer with sentinel node metastasis: a meta-analysis. Eur J Surg Oncol. 2015;41:958–66.

    CAS  PubMed  Google Scholar 

  11. Giuliano AE, Ballman K, McCall L, Beitsch P, Whitworth PW, Blumencranz P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 randomized trial. Ann Surg. 2016;264:413–20.

    PubMed  Google Scholar 

  12. Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318:918–26.

    PubMed  PubMed Central  Google Scholar 

  13. Valero MG, Golshan M. Management of the axilla in early breast cancer. Cancer Treat Res. 2018;173:39–52.

    PubMed  Google Scholar 

  14. Giammarile F, Alazraki N, Aarsvold JN, Audisio RA, Glass E, Grant SF, et al. The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer. Eur J Nucl Med Mol Imaging. 2013;40:1932–47.

    CAS  PubMed  Google Scholar 

  15. Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703–20.

    PubMed  Google Scholar 

  16. Vera DR, Wallace AM, Hoh CK. A synthetic macromolecule for sentinel node detection: 99mTc-DTPA-mannosyl-dextran. J Nucl Med. 2001;42:951–9.

    CAS  PubMed  Google Scholar 

  17. Albo D, Wayne JD, Hunt KK, Rahlfs TF, Singletary SE, Ames FC, et al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg. 2001;182:393–8.

    CAS  PubMed  Google Scholar 

  18. Paganelli G, Luini A, Veronesi U. Radioguided occult lesion localization (ROLL) in breast cancer: maximizing efficacy, minimizing mutilation. Ann Oncol. 2002;13:1839–40.

    CAS  PubMed  Google Scholar 

  19. Jakub JW, Gray RJ, Degnim AC, Boughey JC, Gardner M, Cox CE. Current status of radioactive seed for localization of non-palpable breast lesions. Am J Surg. 2010;199:522–8.

    PubMed  Google Scholar 

  20. Monti S, Galimberti V, Trifirò G, De Cicco C, Peradze N, Brenelli F, et al. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology. Ann Surg Oncol. 2007;14:2928–31.

    PubMed  Google Scholar 

  21. Vermeeren L, Valdes Olmos RA, Klop WM, Balm AJ, van den Brekel MW. A portable gamma-camera for intraoperative detection of sentinel nodes in the head and neck region. J Nucl Med. 2010;51:700–3.

    PubMed  Google Scholar 

  22. Ahmed M, Purushotham AD, Douek M. Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic review. Lancet Oncol. 2014;15:e351–62.

    PubMed  Google Scholar 

  23. Nieweg OE, Uren RF, Thompson JF. Radioguided sentinel lymph node mapping and biopsy in cutaneous melanoma. In: Hermann K, Nieweg OE, Povosky SP, editors. Radioguided surgery. Switzerland: Springer; 2016. p. 152–63.

    Google Scholar 

  24. Lens MB, Dawes M, Newton-Bishop JA, Goodacre T. Tumour thickness as a predictor of occult lymph node metastases in patients with stage I and II melanoma undergoing sentinel lymph node biopsy. Br J Surg. 2002;89:1223–7.

    CAS  PubMed  Google Scholar 

  25. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199–206.

    PubMed  PubMed Central  Google Scholar 

  26. Mariani G, Gipponi M, Moresco L, Villa G, Bartolomei M, Mazzarol G, et al. Radioguided sentinel lymph node biopsy in malignant cutaneous melanoma. J Nucl Med. 2002;43:811–27.

    PubMed  Google Scholar 

  27. Kretschmer L, Thoms KM, Peeters S, Haenssle H, Bertsch HP, Emmert S. Postoperative morbidity of lymph node excision for cutaneous melanoma-sentinel lymphadenectomy versus complete regional lymph node dissection. Melanoma Res. 2008;18:16–21.

    PubMed  Google Scholar 

  28. Bluemel C, Herrmann K, Giammarile F, Nieweg OE, Dubreuil J, Testori A, et al. EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma. Eur J Nucl Med Mol Imaging. 2015;42:1750–66.

    PubMed  Google Scholar 

  29. Niebling MG, Pleijhuis RG, Bastiaannet E, Brouwers AH, van Dam GM, Hoekstra HJ. A systematic review and meta-analyses of sentinel lymph node identification in breast cancer and melanoma, a plea for tracer mapping. Eur J Surg Oncol. 2016;42(4):466–73.

    CAS  PubMed  Google Scholar 

  30. Vitali GC, Trifirò G, Zonta M, Pennacchioli E, Santoro L, Travaini LL, et al. Lymphoscintigraphy in clinical routine practice: reproducibility and accuracy in melanoma patients with a long-term follow-up. Eur J Surg Oncol. 2014;40:55–60.

    CAS  PubMed  Google Scholar 

  31. Ahmadzadehfar H, Hinz T, Wierzbicki A, Höller T, Habibi E, Wenzel J, et al. Significance of multiple nodal basin drainage in patients with truncal melanoma. Q J Nucl Med Mol Imaging. 2016;60:274–9.

    PubMed  Google Scholar 

  32. Veenstra HJ, Klop WM, Speijers MJ, Lohuis PJ, Nieweg OE, Hoekstra HJ, et al. Lymphatic drainage patterns from melanomas on the shoulder or upper trunk to cervical lymph nodes and implications for the extent of neck dissection. Ann Surg Oncol. 2012;19:3906–12.

    PubMed  PubMed Central  Google Scholar 

  33. Jimenez-Heffernan A, Ellmann A, Sado H, Huić D, Bal C, Parameswaran R, et al. Results of a prospective multicenter international atomic energy agency sentinel node trial on the value of SPECT/CT over planar imaging in various malignancies. J Nucl Med. 2015;56:1338–44.

    CAS  PubMed  Google Scholar 

  34. Vidal M, Vidal-Sicart S, Torres F, Ruiz DM, Paredes P, Pons F. Correlation between theoretical anatomical patterns of lymphatic drainage and lymphoscintigraphy findings during sentinel node detection in head and neck melanomas. Eur J Nucl Med Mol Imaging. 2016;43:626–34.

    CAS  PubMed  Google Scholar 

  35. Batistatou A, Cook MG, Massi D, ESP Dermatopathology Working Group. Histopathology report of cutaneous melanoma and sentinel lymph node in Europe: a web-based survey by the Dermatopathology Working Group of the European Society of Pathology. Virchows Arch. 2009;454:505–11.

    PubMed  Google Scholar 

  36. Mocellin S, Hoon DS, Pilati P, Rossi CR, Nitti D. Sentinel lymph node molecular ultrastaging in patients with melanoma: a systematic review and meta-analysis of prognosis. J Clin Oncol. 2007;25:1588–95.

    PubMed  Google Scholar 

  37. Manca G, Romanini A, Pellegrino D, Borsò E, Rondini M, Orlandini C, et al. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma. J Nucl Med. 2008;49:1769–75.

    PubMed  Google Scholar 

  38. Manca G, Romanini A, Rubello D, Mazzarri S, Boni G, Chiacchio S, et al. A critical reappraisal of false negative sentinel lymph node biopsy in melanoma. Q J Nucl Med Mol Imaging. 2014;58:105–13.

    CAS  PubMed  Google Scholar 

  39. Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF, et al. Final trial report of sentinel node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370:599–609.

    CAS  PubMed  PubMed Central  Google Scholar 

  40. McMasters KM, Chao C, Wong SL, Wrightson WR, Ross MI, Reintgen DS, et al. Interval sentinel lymph nodes in melanoma. Arch Surg. 2002;137:543–9.

    PubMed  Google Scholar 

  41. Jimenez RE, Panageas K, Busam KJ, Brady MS. Prognostic implications of multiple lymphatic basin drainage in patients with truncal melanoma. J Clin Oncol. 2005;23:518–24.

    PubMed  Google Scholar 

  42. Ipenburg NA, Nieweg OE, Uren RF, Thompson JF. Outcome of melanoma patients who did not proceed to sentinel node biopsy after preoperative lymphoscintigraphy. Ann Surg Oncol. 2017;24:117–26.

    PubMed  Google Scholar 

  43. Wong SL, Balch CM, Hurley P, Agarwala SS, Akhurst TJ, Cochran A, et al. Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. Ann Surg Oncol. 2012;19:3313–24.

    PubMed  Google Scholar 

  44. Siegel RL, Miller KD, Ahmedin Jemal DVM. Cancer statistics 2017. CA Cancer J Clin. 2017;67:7–30.

    PubMed  Google Scholar 

  45. Gil Z, Carlson DL, Boyle JO, Kraus DH, Shah JP, Shaha AR, et al. Lymph node density is a significant predictor of outcome in patients with oral cancer. Cancer. 2009;115:5700–10.

    PubMed  Google Scholar 

  46. Alex JC, Sasaki CT, Krag DN, Wenig B, Pyle PB. Sentinel lymph node radiolocalization in head and neck squamous cell carcinoma. Laryngoscope. 2000;110:198–203.

    CAS  PubMed  Google Scholar 

  47. Burusapat C, Jarungroongruangchai W, Charoenpitakchai M. Prognostic factors of cervical node status in head and neck squamous cell carcinoma. World J Surg Oncol. 2015;13:51.

    PubMed  PubMed Central  Google Scholar 

  48. NCCN Clinical Practice Guideline in Oncology. Head and Neck Cancer (Version 2.2017). ttps://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf

  49. Murer K, Huber GF, Haile SR, Stoeckli SJ. Comparison of morbidity between sentinel node biopsy and elective neck dissection for treatment of the n0 neck in patients with oral squamous cell carcinoma. Head Neck. 2011;33:1260–4.

    PubMed  Google Scholar 

  50. Liu M, Wang SJ, Yang X, Peng H. Diagnostic efficacy of sentinel lymph node biopsy in early oral squamous cell carcinoma: a meta-analysis of 66 studies. PLoS One. 2017;12(1):e0170322. https://doi.org/10.1371/journal.pone.0170322.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Yamauchi K, Kogashiwa Y, Nakamura T, Moro Y, Nagafuji H, Kohno N. Diagnostic evaluation of sentinel lymph node biopsy in early head and neck squamous cell carcinoma: a meta-analysis. Head Neck. 2015;37:127–33.

    PubMed  Google Scholar 

  52. Robbins KT, Clayman G, Levine PA, Medina J, Sessions R, Shaha A, et al. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol Head Neck Surg. 2002;128:751–8.

    PubMed  Google Scholar 

  53. AJCC. Cancer staging handbook. 7th ed. New York: Springer; 2010.

    Google Scholar 

  54. Creighton F, Bergmark R, Emerick K. Drainage patterns to nontraditional nodal regions and level IIB in cutaneous head and neck malignancy. Otolaryngol Head Neck Surg. 2016;155:1005–11.

    PubMed  Google Scholar 

  55. de Bree R, Nieweg OE. The history of sentinel node biopsy in head and neck cancer: From visualization of lymphatic vessels to sentinel nodes. Oral Oncol. 2015;51:819–23.

    PubMed  Google Scholar 

  56. Shoaib T, Soutar DS, MacDonald DG, Gray HW, Ross GL. The nodal neck level of sentinel lymph nodes in mucosal head and neck cancer. Br J Plast Surg. 2005;8:790–4.

    Google Scholar 

  57. Azad AK, Rajaram MV, Metz WL, Cope FO, Blue MS, Vera DR, et al. γ-Tilmanocept, a new radiopharmaceutical tracer for cancer sentinel lymph nodes, binds to the mannose receptor (CD206). J Immunol. 2015;195:2019–29.

    CAS  PubMed  PubMed Central  Google Scholar 

  58. Agrawal A, Civantos FJ, Brumund KT, Chepeha DB, Hall NC, Carroll WR, et al. [99mTc]Tilmanocept accurately detects sentinel lymph nodes and predicts node pathology status in patients with oral squamous cell carcinoma of the head and neck: results of a phase III multi-institutional trial. Ann Surg Oncol. 2015;22:3708–15.

    PubMed  PubMed Central  Google Scholar 

  59. Peng H, Wang SJ, Niu X, Yang X, Chi C, Zhang G. Sentinel node biopsy using indocyanine green in oral/oropharyngeal cancer. World J Surg Oncol. 2015;13:278.

    PubMed  PubMed Central  Google Scholar 

  60. van den Berg NS, Brouwer OR, Klop WM, Karakullukcu B, Zuur CL, Tan IB, et al. Concomitant radio- and fluorescence-guided sentinel lymph node biopsy in squamous cell carcinoma of the oral cavity using ICG-99mTc-nanocolloid. Eur J Nucl Med Mol Imaging. 2012;39:1128–36.

    CAS  PubMed  Google Scholar 

  61. Khafif A, Schneebaum S, Fliss DM, Lerman H, Metser U, Ben-Yosef R, et al. Lymphoscintigraphy for sentinel node mapping using a hybrid single photon emission CT (SPECT)/CT system in oral cavity squamous cell carcinoma. Head Neck. 2006;28:874–9.

    PubMed  Google Scholar 

  62. den Toom IJ, van Schie A, van Weert S, Karagozoglu KH, Bloemena E, Hoekstra OS, et al. The added value of SPECT-CT for the identification of sentinel lymph nodes in early stage oral cancer. Eur J Nucl Med Mol Imaging. 2017;44:998–1004.

    Google Scholar 

  63. Sieira-Gil R, Paredes P, Martí-Pagés C, Ferrer-Fuertes A, García-Díez E, Cho-Lee GY, et al. SPECT-CT and intraoperative portable gamma-camera detection protocol for sentinel lymph node biopsy in oral cavity squamous cell carcinoma. J Craniomaxillofac Surg. 2015;43:2205–13.

    PubMed  Google Scholar 

  64. Borbón-Arce M, Brouwer OR, van den Berg NS, Mathéron H, Klop WM, Balm AJ, et al. An innovative multimodality approach for sentinel node mapping and biopsy in head and neck malignancies. Rev Esp Med Nucl Imagen Mol. 2014;33:274–9.

    PubMed  Google Scholar 

  65. Hellingman D, Vidal-Sicart S, de Wit-van der Veen LJ, Paredes P, Valdés Olmos RA. A new portable hybrid camera for fused optical and scintigraphic imaging: first clinical experiences. Clin Nucl Med. 2016;41:39–43.

    Google Scholar 

  66. Hermanek P, Hutter RV, Sobin LH, Wittekind C. International Union Against Cancer. Classification of isolated tumor cells and micrometastasis. Cancer. 1999;86:2668–73.

    CAS  PubMed  Google Scholar 

  67. Kovács AF, Stefenelli U, Seitz O, Middendorp M, Diener J, Sader R, et al. Positive sentinel lymph nodes are a negative prognostic factor for survival in T1–2 oral/oropharyngeal cancer – a long-term study on 103 patients. Ann Surg Oncol. 2009;16:233–9.

    PubMed  Google Scholar 

  68. Alkureishi LW, Ross GL, Shoaib T, Soutar DS, Robertson AG, Thompson R, et al. Sentinel node biopsy in head and neck squamous cell cancer: 5-year follow-up of a European multicenter trial. Ann Surg Oncol. 2010;17:2459–64.

    PubMed  Google Scholar 

  69. Broglie MA, Haile SR, Stoeckli SJ. Long-term experience in sentinel node biopsy for early oral and oropharyngeal squamous cell carcinoma. Ann Surg Oncol. 2011;18:2732–8.

    PubMed  Google Scholar 

  70. Govers TM, Hannink G, Merkx MA, Takes RP, Rovers MM. Sentinel node biopsy for squamous cell carcinoma of the oral cavity and oropharynx: a diagnostic meta-analysis. Oral Oncol. 2013;49:726–32.

    PubMed  Google Scholar 

  71. Den Toom IJ, Heuveling DA, Flach GB, van Weert S, Karagozoglu KH, van Schie A, et al. Sentinel node biopsy for early oral cavity cancer: the VU University Medical Center experience. Head Neck. 2015;37:573–8.

    Google Scholar 

  72. Schilling C, Stoeckli SJ, Haerle SK, Broglie MA, Huber GF, Sorensen JA, et al. Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer. Eur J Cancer. 2015;51:2777–84.

    PubMed  Google Scholar 

  73. Pedersen NJ, Hebbelstrup Jensen DH, Hedbäck N, Frendø M, Kiss K, Lelkaitis G, et al. Staging of early lymph node metastases with the sentinel lymph node technique and predictive factors in T1/T2 oral cavity cancer: a retrospective single-center study of 253 consecutive patients. Head Neck. 2016;38(Suppl 1):1033–40.

    Google Scholar 

  74. Den Toom IJ, Bloemena E, van Weert S, Karagozoglu KH, Hoekstra OS, de Bree R. Additional non-sentinel lymph node metastases in early oral cancer patients with positive sentinel lymph nodes. Eur Arch Otorhinolaryngol. 2017;274:961–8.

    Google Scholar 

  75. Alkureishi LW, Burak Z, Alvarez JA, Ballinger J, Bilde A, Britten AJ, et al. Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma. Eur J Nucl Med Mol Imaging. 2009;36:1915–36.

    PubMed  PubMed Central  Google Scholar 

  76. Bluemel C, Rubello D, Colletti PM, de Bree R, Herrmann K. Sentinel lymph node biopsy in oral and oropharyngeal squamous cell carcinoma: current status and unresolved challenges. Eur J Nucl Med Mol Imaging. 2015;42:1469–80.

    PubMed  Google Scholar 

  77. Flach GB, Broglie MA, van Schie A, Bloemena E, Leemans CR, de Bree R, et al. Sentinel node biopsy for oral and oropharyngeal squamous cell carcinoma in the previously treated neck. Oral Oncol. 2012;48:85–9.

    PubMed  Google Scholar 

  78. Giammarile F, Bozkurt MF, Cibula D, Pahisa J, Oyen WJ, Paredes P, et al. The EANM clinical and technical guidelines for lymphoscintigraphy and sentinel node localization in gynaecological cancers. Eur J Nucl Med Mol Imaging. 2014;41:1463–77.

    PubMed  Google Scholar 

  79. Collarino A, Donswijk ML, van Driel WJ, Stokkel MP, Valdés Olmos RA. The use of SPECT/CT for anatomical mapping of lymphatic drainage in vulvar cancer: possible implications for the extent of inguinal lymph node dissection. Eur J Nucl Med Mol Imaging. 2015;42:2064–71.

    PubMed  Google Scholar 

  80. Hoogendam JP, Veldhuis WB, Hobbelink MG, Verheijen RH, van den Bosch MA, Zweemer RP. 99mTc SPECT/CT versus planar lymphoscintigraphy for preoperative sentinel lymph node detection in cervical cancer: a systematic review and metaanalysis. J Nucl Med. 2015;56:675–80.

    PubMed  Google Scholar 

  81. Ouldamer L, Bendifallah S, Body G, Canlorbe G, Touboul C, Graesslin O, et al. Call for surgical nodal staging in women with ESMO/ESGO/ESTRO high-intermediate risk endometrial cancer: a multicentre cohort analysis from the FRANCOGYN study group. Ann Surg Oncol. 2017;24:1660–6.

    CAS  PubMed  Google Scholar 

  82. Elisei F, Crivellaro C, Giuliani D, Dolci C, De Ponti E, Montanelli L, et al. Sentinel-node mapping in endometrial cancer patients: comparing SPECT/CT, gamma-probe and dye. Ann Nucl Med. 2017;3:93–9.

    Google Scholar 

  83. Klapdor R, Hertel H, Soergel P, Jentschke M, Hillemanns P. Application of sentinel lymph node dissection in gynecological cancers: results of a survey among German hospitals. Arch Gynecol Obstet. 2017;295:713–20.

    PubMed  Google Scholar 

  84. Te Grootenhuis NC, van der Zee AG, van Doorn HC, van der Velden J, Vergote I, Zanagnolo V, et al. Sentinel nodes in vulvar cancer: long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I. Gynecol Oncol. 2016;140:8–14.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria

    Francesco Giammarile

  2. Nuclear Medicine Department, University Hospital Clinic, Barcelona, Spain

    Sergi Vidal-Sicart

  3. Nuclear Medicine Unit, “Maggiore della Carità” University Hospital, Novara, Italy

    Federica Orsini

  4. Nuclear Medicine Section and Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Centre, Leiden, The Netherlands

    Renato A. Valdés Olmos

  5. Nuclear Medicine Department, Onze Lieve Vrouwe Gasthuis Hospital, Amsterdam, The Netherlands

    Renato A. Valdés Olmos

  6. Regional Center of Nuclear Medicine, Department of Translational Research and Advanced Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy

    Giuliano Mariani

Authors
  1. Francesco Giammarile
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sergi Vidal-Sicart
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Federica Orsini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Renato A. Valdés Olmos
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Giuliano Mariani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giuliano Mariani .

Editor information

Editors and Affiliations

  1. Regional Center of Nuclear Medicine, Department of Translational Research and Advanced Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy

    Duccio Volterrani

  2. Regional Center of Nuclear Medicine, Department of Translational Research and Advanced Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy

    Paola Anna Erba

  3. Hosp. Sant Pau, Nuclear Medicine Department, Autonomous University of Barcelona, Barcelona, Spain

    Ignasi Carrió

  4. Molecular Imaging and Therapy Department, Cornell University Weill, New York, NY, USA

    H. William Strauss

  5. Regional Center of Nuclear Medicine, Department of Translational Research and Advanced Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy

    Giuliano Mariani

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Giammarile, F., Vidal-Sicart, S., Orsini, F., Valdés Olmos, R.A., Mariani, G. (2019). Image-Guided and Radioguided Surgery. In: Volterrani, D., Erba, P.A., Carrió, I., Strauss, H.W., Mariani, G. (eds) Nuclear Medicine Textbook. Springer, Cham. https://doi.org/10.1007/978-3-319-95564-3_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-95564-3_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-95563-6

  • Online ISBN: 978-3-319-95564-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation